Fig. 2

Expression of Erbin in different types of immune cells and the effects of Erbin deletion on immune cells. a The mRNA level of Erbin in NK cells (NK), Dendritic cells (DC), Monocytes, B cells, T cells, and Neutrophil cells in splenic leukocytes (SPL). b The mRNA level of Erbin in the pro, pre, immature and mature phases of B cells in bone marrow (BM). c The mRNA level of Erbin in Naive B, Memory B, Plasma B cells (PC), Breg in splenic leukocytes (SPL). d–h Proportion of B220⁺ cells, CD3⁺ cells, CD49b⁺ cells, CD11c⁺ cells, and CD11b⁺ cells in leukocytes of spleen, blood, lung, liver, and gut in Erbin full knockout (Erbin^−/−) mice. i–m Proportion of Naive B cells, Memory B cells, Plasma cells (PC), and Breg cells of spleen, blood, lung, liver, and gut in Erbin^−/− mice. n–r Proportion of Naive B cells, Memory B cells, Plasma cells (PC), and Breg cells of spleen, blood, lung, liver, and gut in cKO mice. s–t Proportion of IgA⁺/IgG⁺/IgM⁺ CD138⁺ cells of lung leukocytes in Erbin^−/− mice (s) and WT vs cKO mice (t). *p < 0.05 (Student t test)